Peripheral blood leukocyte production of BDNF following mitogen stimulation in early onset and regressive autism

Amanda Enstrom, Charity Onore, Angela Tarver, Irva Hertz-Picciotto, Robin L Hansen, Lisa Croen, Judith A Van de Water, Paul Ashwood

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Brain-derived neurotrophic factor (BDNF) is critical for neuronal differentiation and synaptic development. BDNF is also implicated in the development of psychological disorders including depression, bipolar disorder and schizophrenia. Previously, elevated BDNF levels were observed in neonatal blood samples from infants who were later diagnosed with autism when compared with children who developed normally, suggesting that BDNF may be involved in the development of autism. BDNF is produced by activated brain microglial cells, a cellular phenotype that shares several features with peripheral macrophages, suggesting an important role for the immune system in BDNF production. We hypothesized that under mitogenic stimulation, peripheral blood mononuclear cells obtained from children with autism may have altered BDNF production compared with age-matched typically developing control subjects. In addition, we examined the differences between the production of BDNF in classic/early-onset autism and children who had a regressive form of autism. We show here that plasma levels of BDNF levels are increased in children with autism, especially in early onset autism subjects. Furthermore, under mitogenic stimulation with PHA and LPS, BDNF production is significantly increased in children with autism compared with typically developing subjects. However, stimulation with tetanus toxoid results in a decreased response in children with autism. This data suggest that immune cell-derived production of BDNF could be an important source for the increased BDNF that is detected in some subjects with autism. As a neurotrophic factor produced by immune cells, BDNF could help elucidate the role of the immune system in neurodevelopment and neuronal maintenance, which may be dysregulated in autism.

Original languageEnglish (US)
Pages (from-to)121-129
Number of pages9
JournalAmerican Journal of Biochemistry and Biotechnology
Volume4
Issue number2
StatePublished - 2008

Fingerprint

Brain-Derived Neurotrophic Factor
Autistic Disorder
Mitogens
Leukocytes
Blood
Immune system
Immune System
Tetanus Toxoid
Macrophages
Nerve Growth Factors
Bipolar Disorder
Brain
Blood Cells
Schizophrenia
Maintenance

Keywords

  • Autism
  • Brain-derived neurotrophic factor (BDNF)
  • Inflammation
  • Luminex
  • Neurotrophin

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology

Cite this

@article{c352302524ce41679c863a979e7f91ed,
title = "Peripheral blood leukocyte production of BDNF following mitogen stimulation in early onset and regressive autism",
abstract = "Brain-derived neurotrophic factor (BDNF) is critical for neuronal differentiation and synaptic development. BDNF is also implicated in the development of psychological disorders including depression, bipolar disorder and schizophrenia. Previously, elevated BDNF levels were observed in neonatal blood samples from infants who were later diagnosed with autism when compared with children who developed normally, suggesting that BDNF may be involved in the development of autism. BDNF is produced by activated brain microglial cells, a cellular phenotype that shares several features with peripheral macrophages, suggesting an important role for the immune system in BDNF production. We hypothesized that under mitogenic stimulation, peripheral blood mononuclear cells obtained from children with autism may have altered BDNF production compared with age-matched typically developing control subjects. In addition, we examined the differences between the production of BDNF in classic/early-onset autism and children who had a regressive form of autism. We show here that plasma levels of BDNF levels are increased in children with autism, especially in early onset autism subjects. Furthermore, under mitogenic stimulation with PHA and LPS, BDNF production is significantly increased in children with autism compared with typically developing subjects. However, stimulation with tetanus toxoid results in a decreased response in children with autism. This data suggest that immune cell-derived production of BDNF could be an important source for the increased BDNF that is detected in some subjects with autism. As a neurotrophic factor produced by immune cells, BDNF could help elucidate the role of the immune system in neurodevelopment and neuronal maintenance, which may be dysregulated in autism.",
keywords = "Autism, Brain-derived neurotrophic factor (BDNF), Inflammation, Luminex, Neurotrophin",
author = "Amanda Enstrom and Charity Onore and Angela Tarver and Irva Hertz-Picciotto and Hansen, {Robin L} and Lisa Croen and {Van de Water}, {Judith A} and Paul Ashwood",
year = "2008",
language = "English (US)",
volume = "4",
pages = "121--129",
journal = "American Journal of Biochemistry and Biotechnology",
issn = "1553-3468",
publisher = "Science Publications",
number = "2",

}

TY - JOUR

T1 - Peripheral blood leukocyte production of BDNF following mitogen stimulation in early onset and regressive autism

AU - Enstrom, Amanda

AU - Onore, Charity

AU - Tarver, Angela

AU - Hertz-Picciotto, Irva

AU - Hansen, Robin L

AU - Croen, Lisa

AU - Van de Water, Judith A

AU - Ashwood, Paul

PY - 2008

Y1 - 2008

N2 - Brain-derived neurotrophic factor (BDNF) is critical for neuronal differentiation and synaptic development. BDNF is also implicated in the development of psychological disorders including depression, bipolar disorder and schizophrenia. Previously, elevated BDNF levels were observed in neonatal blood samples from infants who were later diagnosed with autism when compared with children who developed normally, suggesting that BDNF may be involved in the development of autism. BDNF is produced by activated brain microglial cells, a cellular phenotype that shares several features with peripheral macrophages, suggesting an important role for the immune system in BDNF production. We hypothesized that under mitogenic stimulation, peripheral blood mononuclear cells obtained from children with autism may have altered BDNF production compared with age-matched typically developing control subjects. In addition, we examined the differences between the production of BDNF in classic/early-onset autism and children who had a regressive form of autism. We show here that plasma levels of BDNF levels are increased in children with autism, especially in early onset autism subjects. Furthermore, under mitogenic stimulation with PHA and LPS, BDNF production is significantly increased in children with autism compared with typically developing subjects. However, stimulation with tetanus toxoid results in a decreased response in children with autism. This data suggest that immune cell-derived production of BDNF could be an important source for the increased BDNF that is detected in some subjects with autism. As a neurotrophic factor produced by immune cells, BDNF could help elucidate the role of the immune system in neurodevelopment and neuronal maintenance, which may be dysregulated in autism.

AB - Brain-derived neurotrophic factor (BDNF) is critical for neuronal differentiation and synaptic development. BDNF is also implicated in the development of psychological disorders including depression, bipolar disorder and schizophrenia. Previously, elevated BDNF levels were observed in neonatal blood samples from infants who were later diagnosed with autism when compared with children who developed normally, suggesting that BDNF may be involved in the development of autism. BDNF is produced by activated brain microglial cells, a cellular phenotype that shares several features with peripheral macrophages, suggesting an important role for the immune system in BDNF production. We hypothesized that under mitogenic stimulation, peripheral blood mononuclear cells obtained from children with autism may have altered BDNF production compared with age-matched typically developing control subjects. In addition, we examined the differences between the production of BDNF in classic/early-onset autism and children who had a regressive form of autism. We show here that plasma levels of BDNF levels are increased in children with autism, especially in early onset autism subjects. Furthermore, under mitogenic stimulation with PHA and LPS, BDNF production is significantly increased in children with autism compared with typically developing subjects. However, stimulation with tetanus toxoid results in a decreased response in children with autism. This data suggest that immune cell-derived production of BDNF could be an important source for the increased BDNF that is detected in some subjects with autism. As a neurotrophic factor produced by immune cells, BDNF could help elucidate the role of the immune system in neurodevelopment and neuronal maintenance, which may be dysregulated in autism.

KW - Autism

KW - Brain-derived neurotrophic factor (BDNF)

KW - Inflammation

KW - Luminex

KW - Neurotrophin

UR - http://www.scopus.com/inward/record.url?scp=42449113260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42449113260&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:42449113260

VL - 4

SP - 121

EP - 129

JO - American Journal of Biochemistry and Biotechnology

JF - American Journal of Biochemistry and Biotechnology

SN - 1553-3468

IS - 2

ER -